Blue Heron to Supply Genes to Venter s New Synthetic Genomics Company | GenomeWeb

NEW YORK, July 7 (GenomeWeb News) - Blue Heron Biotechnology will build and supply genes to Craig Venter's new synthetic biology company, according to people familiar with the arrangement.

 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.